With the many changes occurring in today's healthcare organizations, patients are increasingly equipped with a vast quantity of health care data and being more included in the healthcare decision-making process. The new approach we propose incorporates a new patient-organization framework that examines relevant historical, legal and ethical elements within the doctrine of informed consent in addition to examining the role of new healthcare organizations' obligations to include data to support addressing issues such as population health, health outcomes and health disparities within the informed consent. There is a growing consensus among healthcare professionals that using an evidencebased organizational informed consent framework to improve the informed consent process can lead to better comprehension, health outcomes, transparency and improved patient trust and retention overall.
Get full access to this article
View all access options for this article.
References
1.
Y.Schenker and A.Meisel, “Informed Consent in Clinical Care: Practical Considerations in the Effort to Achieve Ethical Concerns,”JAMA35, no. 11 (2011): 1130-1131.
2.
W. J.Friedlander, “The Evolution of Informed Consent in American Medicine,”Perspectives in Biology and Medicine38, no. 3 (1995): 498-510.
3.
O. W.Holmes, “The Young Practitioner,” in Medical Essays, 1842-1882 (Boston: Houghton Mifflin, 1911): at 388-389.
4.
R.Baker, Before Bioethics: A History of American Medical Ethics from the Colonial Period to the Bioethics Revolution (Oxford University Press, 2013): at 233.
5.
Schloendorff v. Society of New York Hospitals, 211 NY 128, 105 NE 93(1914).
6.
P.Nelson-Marten and B.Rich, “A Historical Perspective of Informed Consent in Clinical Practice and Research,”Seminars in Oncology Nursing15, no. 2 (1999): 81-88.
J. H.Krause, “Reconceptualizing Informed Consent in an Era of Health Care Cost Containment,”Iowa Law Review85, no. 1 (1999): 261-386, at 275.
11.
M.Alan and H. R.Loren, “Toward an Informed Discussion of Informed Consent: Review and Critique of the Empirical Studies,”Arizona Law Review25, no. 2 (1983): 265-346, at 265, 283, 306.
12.
J.Katz, “Informed Consent — Must It Remain a Fairy Tale?”Journal of Contemporary Health Law and Policy10, no. 1 (1994): 69-91.
13.
S. M.Wolf, “Toward a Systemic Theory of Informed Consent in Managed Care,”Houston Law Review3, no. 5 (1999): 1631-81.
14.
M. B.Rothberg, S. K.Sivalingam, and J.Ashrafet al., “Patients' and Cardiologists' Perceptions of the Benefits of Percutaneous Coronary Intervention for Stable Coronary Disease,”Annals of Internal Medicine153, no. 5 (2010): 307-313.
15.
F.Wood, S. M.Martin, and A.Carson-Stevenset al., “Doctor's Perspectives of Informed Consent for Non-Emergency Surgical Procedures: A Qualitative Interview Study,”Health Expectations19, no. 3 (2014): 751-761.
16.
R. L.Sudore, C. S.Landefeld, and B. A.Williamset al., “Use of a Modified Informed Consent Process among Vulnerable Patients,”Journal of General Internal Medicine21, no. 8 (2006): 867-873.
17.
See Wolf, supra note 12, at 1638.
18.
Pub. L. 104-191, 110 Stat. 1988 (1996) (codified in scattered sections of 29 U.S.C., 42 U.S.C., and 18 U.S.C.).
19.
Title II, Subtitle F of the HIPAA.
20.
F.Miller, “Health Care Information Technology and Informed Consent: Computers and the Doctor-Patient Relationship,”Indiana Law Review31, no. 4 (1998): 1019-1042, at 1026.
21.
B.Jennings, M. A.Baily, M.Bottrell, and J.Lynn, eds., Health Care Quality Improvement: Ethical and Regulatory Issues (New York: The Hastings Center, 2007): at 16-27.
S. D.Pearson, J.Sabin, and E. J.Emanuel, No Margin, No Mission: Health-Care Organizations and the Quest for Ethical Excellence (Cary, NC: Oxford University Press, 2003): at 42.
H. J.Silverman, “Organizational Ethics in Healthcare Organizations: Proactively Managing the Ethical Climate to Ensure Organizational Integrity,”HEC Forum12, no. 3 (2000): 202-215.
27.
E. H.Morreim, “To Tell the Truth: Disclosing the Incentives and Limits of Managed Care,”American Journal of Managed Care3, no. 1 (1997): 35-43.
28.
J.Floyd, F. J.Fowler, C. A.Levin, and K. R.Sepucha, “Informing and Involving Patients to Improve the Quality of Medical Decisions,”Health Affairs30, no. 4 (2011): at 699-706.
29.
B. J.Zikmund-Fisher, M. P.Couper, and E.Singeret al., “The Decisions Study: A National Wide Survey of US Adults Regarding Nine Common Medical Decisions,”Medical Decision Making30, no. 5, Supp. (2010): S20-S34.
30.
See Katz, supra note 11, at 154.
31.
G. F.Tietz, “Informed Consent in the Prescription Drug Context: The Special Case,”Washington Law Review61, no. 2 (1986): 367-417.
32.
E. H.Morreim, Balancing Act: The New Medical Ethics of Medicine's New Economics (Georgetown University Press, 1995); E. H. Morreim, “Diverse and Perverse Incentives of Managed Care: Bringing Patients Into Alignment,” Widener Law Symposium Journal 1 (1995): 89-139.
33.
E. H.Morreim, “Economic Disclosure and Economic Advocacy,”Journal of Legal Medicine12, no. 3 (1991): 275-329.
34.
P. H.Schuck, “Rethinking Informed Consent,”Yale Law Journal Company103, no. 4 (1994): 899-959.
35.
E. D.Pellegrino, “Hospitals as Moral Agents,” in Humanism and the Physician (Knoxville, TN: University of Tennessee Press, 1979).
